cagA gene therapy (OraVax)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NamecagA gene therapy (OraVax)
Drug Alias NameCagA antigen (Oravax)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHelicobacter pylori infectionPeptic Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAcambis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiomerieux IncAcambis
Active IndicationsN/A
Inactive IndicationsHelicobacter pylori infectionPeptic Ulcer

Other Information

ATC CodeN/A
Related LinksN/A